Education
About Us
Working with TipRanks
Follow Us
Elevance Health, Inc. (ELV)
NYSE:ELV
ELV Stock Chart & Stats
$341.85
<$0.01(<0.01%)
At close: 4:00 PM EST
$341.85
<$0.01(<0.01%)
Day’s Range― - ―
52-Week Range$273.71 - $458.75
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.35M
Market Cap
$71.77B
Enterprise Value$67.73B
Total Cash (Recent Filing)$35.00B
Total Debt (Recent Filing)$32.10B
Price to Earnings (P/E)12.8
Beta0.28
Next Earnings
Apr 22, 2026EPS Estimate
10.61Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)3.33
Shares Outstanding222,238,770
10 Day Avg. Volume1,686,131
30 Day Avg. Volume1,352,085
Financial Highlights & Ratios
PEG Ratio8.48
Price to Book (P/B)2.08
Price to Sales (P/S)0.49
P/FCF Ratio18.87
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue0.35
Enterprise Value/Gross Profit0.45
Enterprise Value/Ebitda6.53
Forecast
1Y Price Target
$396.36Price Target Upside15.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)26.71
Revenue Forecast (FY)$204.69B
Bulls Say, Bears Say
Bulls Say
Guidance And Upside DriversAnalyst upgrade to Outperform reflects that conservatively biased guidance could establish a performance floor and allow identified upside drivers, such as enrollment gains, to reassert the growth story.
Market Sentiment ImprovementEstablishing a bottom in reported results has historically led to improved market sentiment for similar companies, suggesting analyst upgrades may draw renewed investor interest.
Medical Cost TrendsMedical cost trends came in line to slightly better than prior estimates, which could support margin stability and reduce downside risk to earnings.
Bears Say
Carelon Execution RiskExpected shifts and the timing of Carelon's transformation could have a larger-than-anticipated impact on results, increasing near-term volatility in the company's financial outlook.
Health Benefits Margins And Policy RiskHealth Benefits margins face pressure from potential membership declines in Medicare Advantage and exchange channels and from the possible expiration of enhanced premium supports, weighing on near-term profitability.
Medicaid Segment UncertaintyTiming and performance in the Medicaid business are a key uncertainty that could limit near-term upside if outcomes are unfavorable.
Elevance Health News
ELV FAQ
What was Elevance Health, Inc.’s price range in the past 12 months?
Elevance Health, Inc. lowest stock price was $273.71 and its highest was $458.75 in the past 12 months.
What is Elevance Health, Inc.’s market cap?
Elevance Health, Inc.’s market cap is $71.77B.
When is Elevance Health, Inc.’s upcoming earnings report date?
Elevance Health, Inc.’s upcoming earnings report date is Apr 22, 2026 which is in 83 days.
How were Elevance Health, Inc.’s earnings last quarter?
Elevance Health, Inc. released its earnings results on Jan 28, 2026. The company reported $3.33 earnings per share for the quarter, beating the consensus estimate of $3.096 by $0.234.
Is Elevance Health, Inc. overvalued?
According to Wall Street analysts Elevance Health, Inc.’s price is currently Undervalued.
Does Elevance Health, Inc. pay dividends?
Elevance Health, Inc. pays a Quarterly dividend of $1.71 which represents an annual dividend yield of 1.99%. See more information on Elevance Health, Inc. dividends here
What is Elevance Health, Inc.’s EPS estimate?
Elevance Health, Inc.’s EPS estimate is 10.61.
How many shares outstanding does Elevance Health, Inc. have?
Elevance Health, Inc. has 222,238,770 shares outstanding.
What happened to Elevance Health, Inc.’s price movement after its last earnings report?
Elevance Health, Inc. reported an EPS of $3.33 in its last earnings report, beating expectations of $3.096. Following the earnings report the stock price went up 5.862%.
Which hedge fund is a major shareholder of Elevance Health, Inc.?
Currently, no hedge funds are holding shares in ELV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$396.36 (15.95% Upside)
$396.36 (15.95% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 55%
Bearish news 45%
Bearish news 45%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.04%
12-Months-Change
Fundamentals
Return on Equity
13.29%
Trailing 12-Months
Asset Growth
3.94%
Trailing 12-Months
Company Description
Elevance Health, Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
ELV Company Deck
ELV Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced significant near-term challenges—notably membership declines (Medicaid and Medicare), elevated cost trends, a negative Medicaid margin expectation for 2026, and a lower 2026 EPS baseline versus 2025—with several constructive positives: strong Q4 revenue, Carillon growth and external demand, disciplined pricing and portfolio repositioning, targeted investments in analytics and care management, healthy ASO sales momentum, and a clear plan to return to at least 12% EPS growth in 2027. Management emphasized prudent assumptions and execution, but material near-term headwinds and margin recalibrations reduce upside in 2026.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$396.36
▲(15.95% Upside)
Technical Analysis
Ownership Overview
0.14% Insiders
27.13% Mutual Funds
0.64% Other Institutional Investors
48.97% Public Companies and Individual Investors